Besides the diabetes and obesity duo of Mounjaro and Zepbound, the SGLT2 inhibitor Jardiance and the CDK4/6 cancer drug Verzenio were cited as the main growth drivers for Eli Lilly’s first quarter.
What's worse, these sub-par tablets can cost the same, or sometimes more, than the models that beat them in every way. That’s why our lab tests and reviews are so important. There are also different ...
Samsung makes more Android tablets than anyone else, but are they right for you? Check our best Android tablets to see what we recommend from the likes of Lenovo and Xiaomi Samsung has the expertise ...
Tablets are getting cheaper but you’ll still have to set aside at least £100 for even the most basic models, and if you want the best devices available you’re looking at upwards of £1,000 ...
Inside this compact, letterbox-friendly foil bag – which uses less plastic than conventional pill bottles – are 180 tiny tablets measuring 6mm, each delivering a high-quality 1,000IU vitamin D ...
Nokia used to be one of the world's biggest mobile phone manufacturers but it fell behind with the advent of iPhone and Android smartphones. In 2014, Nokia's Devices and Services division was sold to ...
It is also the largest telecom infrastructure maker in the world. The company also makes Android smartphones and tablets. Recently it has stepped into the smartwatch market with an Android Wear based ...
As part of its quar­ter­ly clean­ing, Eli Lil­ly re­moved a few tri­als from its pipeline, in­clud­ing late-stage stud­ies of ap­proved can­cer drug Verzenio and its Boehringer In­gel ...
UK pharma major GSK has announced positive results from the pivotal EAGLE-1 Phase III trial for gepotidacin, a potential first-in-class oral antibiotic with a novel mechanism of action for ...
Saint Luke’s Mid America Heart Institute, Kansas City, MO (M.E.N., M.Q., S.L.W., F.T., M.N.K.). University of Missouri–Kansas City (M.E.N., M.Q., M.N.K.). Saint ...
motorola India is all set to launch its first earbuds in the country. The two earbuds named moto buds and ...